Reaction Details Report a problem with these data
Target
Free fatty acid receptor 1
Ligand
BDBM300871
Substrate
n/a
Meas. Tech.
GPR40 Calcium Flux Assay
EC50
15.0±n/a nM
Citation
 Huang, H; Kuo, G; Player, MR; Yang, S; Zhang, Y Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes US Patent  US10131648 Publication Date 11/20/2018 
Target
Name:
Free fatty acid receptor 1
Synonyms:
FFAR1 | FFAR1_HUMAN | G-protein Coupled Receptor 40 | GPR40
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
31473.32
Organism:
Homo sapiens (Human)
Description:
O14842
Residue:
300
Sequence:
MDLPPQLSFGLYVAAFALGFPLNVLAIRGATAHARLRLTPSLVYALNLGCSDLLLTVSLPLKAVEALASGAWPLPASLCPVFAVAHFFPLYAGGGFLAALSAGRYLGAAFPLGYQAFRRPCYSWGVCAAIWALVLCHLGLVFGLEAPGGWLDHSNTSLGINTPVNGSPVCLEAWDPASAGPARFSLSLLLFFLPLAITAFCYVGCLRALARSGLTHRRKLRAAWVAGGALLTLLLCVGPYNASNVASFLYPNLGGSWRKLGLITGAWSVVLNPLVTGYLGRGPGLKTVCAARTQGGKSQK
  
Inhibitor
Name:
BDBM300871
Synonyms:
(3S)-3-[4-[[3-(2- Methanesulfonylphenyl)-1- benzothiophen-6- yl]methoxy]phenyl) hex-4-ynoic acid | US10131648, Compound 69 | US10195178, Compound 69 | US9790198, Compound 69
Type:
Small organic molecule
Emp. Form.:
C28H24O5S2
Mol. Mass.:
504.617
SMILES:
CC#C[C@@H](CC(O)=O)c1ccc(OCc2ccc3scc(-c4ccccc4S(C)(=O)=O)c3c2)cc1 |r|
Structure:
Search PDB for entries with ligand similarity: